| Field | Specification |
|---|---|
| Gene ID | |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Applications | |
| Conjugate | |
| Concentration | |
| Storage | |
| Storage buffer | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
CD62L is a 74-95 kD glycoprotein also known as L-selectin, LECAM-1, Ly-22, LAM-1, and MEL-14. It is a member of the selectin family and is expressed on the majority of B and naïve T cells, a subset of memory T cells, monocytes, granulocytes, most thymocytes, and a subset of NK cells. CD62L is important in lymphocyte homing to high endothelial venules (HEV) in peripheral lymph nodes and leukocyte 'rolling' on activated endothelium. CD62L also contributes to neutrophil emigration at inflammatory sites. CD62L is rapidly shed from lymphocytes and neutrophils upon cellular activation and the expression levels of CD62L (in conjunction with other markers) have been used to distinguish naïve, effector, and memory T cells. CD62L has been reported to interact with CD34, GlyCAM-1, and MAdCAM-1.
Validated Applications & Recommended Dilutions
| Application | Recommended Dilution |
|---|---|
| Flow Cytometry | See product datasheet |
Antibody Specifications
| Target | CD62L |
|---|---|
| Host Species | Rat |
| Clonality | Monoclonal |
| Isotype | Rat IgG2a, κ |
| Conjugate | APC |
| Clone Number | MEL-14 |
| Purification | See datasheet |
| Concentration | 5 μL/Test |
Immunogen
Recombinant protein fragment; see full datasheet. UniProt: P18337.
Species Reactivity & Cross-Reactivity
Validated for: Mouse. Verify suitability in your sample type prior to use. For species or applications not listed in the datasheet, consult our technical team before purchase.
Storage & Handling
This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.
Storage Buffer: Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Related Products
Browse additional antibodies targeting CD62L and complementary reagents — including secondary antibodies, blocking buffers, and detection kits — available through BioHippo.
This antibody is validated for flow cytometry applications. For intracellular targets, fix and permeabilize cells using a validated fixation/permeabilization kit (e.g., BD Cytofix/Cytoperm or similar) before staining. For surface markers, stain live or fixed cells without permeabilization. Always include a matched isotype control (Rat IgG2a, κ, Rat origin) at the same protein concentration as the test antibody to establish non-specific binding thresholds. Recommended starting dilution/concentration: see datasheet.
This antibody has been experimentally validated in: Mouse. Cross-reactivity with other species has not been systematically evaluated. If your sample species is not listed, assess immunogen sequence homology to your target species ortholog. The immunogen used is: "" — higher sequence identity between species increases the probability of cross-reactivity, but experimental validation with appropriate controls is necessary before drawing scientific conclusions.
This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. Storage Buffer: Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.. To maintain antibody activity, avoid repeated freeze-thaw cycles. Aliquot into single-use volumes before first freeze. If working with the antibody frequently, keep a working stock at 4°C for up to 4 weeks — add 0.02% sodium azide to the working stock as a bacteriostatic agent if azide is not already present in the buffer. Monitor performance against a validated positive control when transitioning between storage aliquots or lots.
This monoclonal antibody (clone MEL-14) provides highly consistent, epitope-specific recognition of CD62L, making it ideal for quantitative assays, multiplex panels, and studies requiring strict reproducibility across experiments and independent laboratories. Unlike polyclonal preparations, each production batch from a single hybridoma clone generates antibody with identical epitope specificity, affinity, and isotype — ensuring reliable signal comparison in longitudinal studies or multi-site collaborations. When citing this antibody in publications, include the clone designation (clone MEL-14) to enable third-party reproducibility verification.
Customization & Add-ons: Can't find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Lymph Node Targeted Drug Delivery for Effective Immunomodulation to Prolong the Long-Term Survival After Heart Transplantation (2022) ADVANCED MATERIALS. 10.1002/adma.202207227
Propionibacterium acnes Cloaked with ZnAl Layered Double Hydroxides Synergistically Inhibits Tumor Growth and Metastasis (2023) ADVANCED FUNCTIONAL MATERIALS. 10.1002/adfm.202214105
An Alternative Thinking in Tumor Therapeutics: Living Yeast Armored with Silicate (2023) ACS Nano. 10.1021/acsnano.3c06311
A Bionic Yeast Tumor Vaccine Using the Co-Loading Strategy to Prevent Post-Operative Tumor Recurrence (2023) ACS Nano. 10.1021/acsnano.3c06115
Ultrathin Oleanolic Acid/Perfluorocarbon-Ferrocene Nanosheets Trigger Reactive Species Storm to Reshape Tumor Microenvironment for Enhanced Chemodynamic Therapy (2026) ACS Nano. 10.1021/acsnano.5c20827
Regulating the Tumor Microbiome through Near-Infrared-III Light-Excited Photosynthesis (2025) ACS Nano. 10.1021/acsnano.4c18954
Programmable Macrophage Vesicle Based Bionic Self-Adjuvanting Vaccine for Immunization against Monkeypox Virus (2024) Advanced Science. 10.1002/advs.202408608
Gold-embedded yolk-shell mesoporous organosilica nanocomposite for microwave-enhanced targeted chemotherapy and immune modulation in hepatocellular carcinoma (2025) BIOMATERIALS. 10.1016/j.biomaterials.2025.123533
A facile microfluidics based polysaccharide-functionalized virus-mimicking nanovaccine for circumventing pulmonary innate physiological barriers and augmenting immunity (2025) CARBOHYDRATE POLYMERS. 10.1016/j.carbpol.2025.124503
Respiratory mucosal vaccination of platycodin-functionalized biomimetic nanovaccines for amplifying immune response (2025) JOURNAL OF CONTROLLED RELEASE. 10.1016/j.jconrel.2025.114074
A Self-Assembled Transdermal Nanomedicines Incorporating Pendant Disulfides for Non-Invasive, Synergistic Treatment of Melanoma (2024) Advanced Healthcare Materials. 10.1002/adhm.202402685
Integration of CoAl-Layered Double Hydroxides on Commensal Bacteria to Enable Targeted Tumor Inhibition and Immunotherapy (2023) ACS Applied Materials & Interfaces. 10.1021/acsami.3c08936
Mucosal Gingipain Vaccine Based on Framework Nucleic Acid Engineering for the Treatment of Periodontitis (2026) ACS Applied Materials & Interfaces. 10.1021/acsami.5c25646
Evaluation and mechanism of immune enhancement effects of Pleurotus ferulae polysaccharides-gold nanoparticles (2022) INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 10.1016/j.ijbiomac.2022.11.277
Nanoformulations Downregulating METTL16 Combined with mRNA Tumor Vaccines Suppress Triple-Negative Breast Cancer and Prevent Metastasis (2025) International Journal of Nanomedicine. 10.2147/IJN.S520329
Chitosan nanoparticles encapsulated with BEZ235 prevent acute rejection in mouse heart transplantation (2023) INTERNATIONAL IMMUNOPHARMACOLOGY. 10.1016/j.intimp.2023.110922
Enhancing neonatal immune maturity: The impact of Bifidobacterium animalis A6 and its postbiotics on NEC outcomes (2025) Food Bioscience. 10.1016/j.fbio.2025.106129
